Search DRIO
DarioHealth Corp.
Nasdaq · CIK 1533998
Last close6.46
Daily change+0.30 (4.87%)
10 Years gain-90.58%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
DRIO · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
34.9Momentum
n/aAcceleration
n/aConfidence
62.0Annual Revenue6
Quarterly Revenue19
Annual CFO10
Balance SheetMissing
RankingLimited
Score Breakdown
Growth25.0 / 25
Quality8.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM46.43%OK
Revenue CAGR 3Y107.89%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $12.67M | -$36.66M | -$25.94M | -$26.08M | n/a | n/a | n/a | -38.6% | 3.98M |
| 2025 FY Dec 31, 2024 | n/a | $13.27M | -$57.74M | -$38.56M | -$38.70M | n/a | n/a | n/a | -74.13% | 2.45M |
| 2024 FY Dec 31, 2023 | n/a | $5.98M | -$56.19M | -$30.38M | -$30.96M | n/a | n/a | n/a | -82.61% | 28.37M |
| 2023 FY Dec 31, 2022 | n/a | $9.66M | -$56.81M | -$47.85M | -$48.29M | n/a | n/a | n/a | -83.64% | 23.64M |
| 2022 FY Dec 31, 2021 | n/a | $3.96M | -$76.49M | -$50.41M | -$50.67M | n/a | n/a | n/a | -245.14% | 16.59M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $7.83M | sum latest 4 fiscal quarters Revenue | OK | 0001144204-19-039235, 0001144204-18-058882 |
| Revenue Growth TTM | 46.43% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001144204-19-039235, 0001144204-18-058882 |
| Revenue CAGR 3Y | 107.89% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001144204-19-015691 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001144204-19-015691 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |
| Gross Margin Delta 3Y | n/a | GrossMargin_current - GrossMargin_3Y_ago | INSUFFICIENT_HISTORY | derived |
| Operating Margin Delta 1Y | n/a | OperatingMargin_current - OperatingMargin_prior_year | INSUFFICIENT_HISTORY | derived |